Negotiations Underway for Production of Tamiflu in China - Health Minister
Posted on: Wednesday, 30 November 2005, 09:00 CST
Text of report in English by official Chinese news agency Xinhua (New China News Agency)
Beijing, 30 November: The Shanghai Pharmaceutical Group is negotiating with Swiss pharmaceutical company Roche Holding AG on the production of Tamiflu in China through technology transfer, Chinese Minister of Health Gao Qiang said here Wednesday [30 November].
An antiviral drug, Tamiflu does not cure human bird flu but can reduce its severity and might slow the spread of a human pandemic.
Gao said at a press conference that the government was improving its emergency plan for a possible bird flu pandemic, which included the research and development of bird flu vaccine for humans and related drugs.
China's home-made human bird flu vaccine is now undergoing clinical tests.
Source: BBC Monitoring Asia Pacific
Related Articles
- Bird Flu and Human Flu Are Differentiated
- Five nations confirm bird flu, China faces battle
- Four nations confirm bird flu, China faces struggle
- Three Nations Confirm Bird Flu, China Faces Struggle
- No Confirmed Cases of Bird Flu in Humans Yet in India: Report
- FDA Approves Faster Test for Bird Flu in Humans
- FDA approves new, faster test for bird flu in humans
- Roundup: Indonesia Wages Tougher War on Bird Flu As Human Infections Up to 12 By Xia Lin
- No Transmission of Bird Flu From Human to Human: Thai PM
- Japan Has First Case of Bird Flu in Human
 |
 |
User Comments (0)
RSS Feeds